Approaches to the assessment of severe asthma: barriers and strategies

References

• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, [Updated 2018]. Available from: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-V1.3-002.pdf. Accessed 12 2, 2018.
   Google Scholar
• McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209(2 Suppl):S28–S33.30453870
   PubMed Web of Science ®Google Scholar
• Cordova-Rivera L, Gibson PG, Gardiner PA, Powell H, McDonald VM. Physical activity and exercise capacity in severe asthma: key clinical associations. J Allergy Clin Immunol Pract. 2018;6(3):814–822. doi:10.1016/j.jaip.2017.09.02229133222
   PubMed Web of Science ®Google Scholar
• Foster JM, McDonald VM, Guo M, Reddel HK. “I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J. 2017;50:3. doi:10.1183/13993003.00711-2017
   Web of Science ®Google Scholar
• Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46(3):622–639. doi:10.1183/13993003.00853-201526206872
   PubMed Web of Science ®Google Scholar
• Hekking PP, Wener RR, Amelink M, et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.04225441637
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.0020201324337046
   PubMed Web of Science ®Google Scholar
• Hiles SA, Harvey ES, McDonald VM, et al. Working while unwell: workplace impairment in people with severe asthma. Clin Exp Allergy. 2018;48(6):650–662. doi:10.1111/cea.1315329676834
   PubMed Web of Science ®Google Scholar
• Wark PA, Hew M, Maltby S, McDonald VM, Gibson PG. Diagnosis and investigation in the severe asthma clinic. Expert Rev Respir Med. 2016;10(5):491–503. doi:10.1586/17476348.2016.116509626967545
   PubMed Web of Science ®Google Scholar
• McDonald VM, Maltby S, Reddel HK, et al. Severe asthma: current management, targeted therapies and future directions-A roundtable report. Respirology. 2017;22(1):53–60. doi:10.1111/resp.1295727905186
   PubMed Web of Science ®Google Scholar
• National AE. Prevention P. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94. doi:10.1016/j.jaci.2007.09.02917983880
   PubMed Web of Science ®Google Scholar
• Upham JW, Chung LP. Optimising treatment for severe asthma. Med J Aust. 2018;209(S2):S22–S27.30453869
   PubMed Web of Science ®Google Scholar
• Chung LP, Hew M, Bardin P, McDonald VM, Upham JW. Managing patients with severe asthma in Australia: current challenges with the existing models of care. Intern Med J. 2018;48(12):1536–1541. doi:10.1111/imj.1410330517993
   PubMed Web of Science ®Google Scholar
• Carr TF, Bleecker E. Asthma heterogeneity and severity. World Allergy Organ J. 2016;9(1):41. doi:10.1186/s40413-016-0118-z27980705
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Kostikas K, Zervas E, et al. Control of asthma in real life: still a valuable goal? Eur Respir Rev. 2015;24(136):361. doi:10.1183/16000617.0000221526028647
   PubMed Web of Science ®Google Scholar
• Gibson P, McDonald VM. Management of severe asthma: targeting the airways, comorbidities and risk factors. Intern Med J. 2017;47(6):623–631. doi:10.1111/imj.1344128580744
   PubMed Web of Science ®Google Scholar
• Tay TR, Lee JW-Y, Hew M. Diagnosis of severe asthma. Med J Aust. 2018;209(2 Suppl):S3–S10.
   Web of Science ®Google Scholar
• Moore VC. Spirometry: step by step. Breathe. 2012;8(3):232. doi:10.1183/20734735.0021711
   Google Scholar
• Ayuk AC, Uwaezuoke SN, Ndukwu CI, et al. Spirometry in asthma care: a review of the trends and challenges in pediatric practice. Clin Med Insights Pediatr. 2017;11:1179556517720675. doi:10.1177/117955651772067528781518
   PubMedGoogle Scholar
• Brannan JD, Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol. 2012;3:460. doi:10.3389/fphys.2012.0046023233839
   PubMed Web of Science ®Google Scholar
• Sanguinetti CM. When to perform a bronchial challenge with mannitol? Multidiscip Respir Med. 2011;6(2):76–78. doi:10.1186/2049-6958-6-2-7622958857
   PubMed Web of Science ®Google Scholar
• Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006;61(9):817–827. doi:10.1136/thx.2005.05609316936238
   PubMed Web of Science ®Google Scholar
• Pijnenburg MW. The role of FeNO in predicting asthma. Front Pediatr. 2019;7:41. doi:10.3389/fped.2019.0004130847334
   PubMed Web of Science ®Google Scholar
• Ruppel GL. What is the clinical value of lung volumes? Respir Care. 2012;57(1):26–38. doi:10.4187/respcare.0137422222123
   PubMed Web of Science ®Google Scholar
• Ritz T, Dahme B, Dubois AB, et al. Guidelines for mechanical lung function measurements in psychophysiology. Psychophysiology. 2002;39(5):546–567.12236321
   PubMed Web of Science ®Google Scholar
• Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016. doi:10.1183/13993003.00016-201628049168
   PubMed Web of Science ®Google Scholar
• Bailey KL. The importance of the assessment of pulmonary function in COPD. Med Clin North Am. 2012;96(4):745–752. doi:10.1016/j.mcna.2012.04.01122793942
   PubMed Web of Science ®Google Scholar
• McDonald VM, Fingleton J, Agusti A. et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits down under international workshop report. Eur Respir J. 2019;1802058. doi:10.1183/13993003.02058-201830846468
   PubMed Web of Science ®Google Scholar
• Fricker M, Heaney LG, Upham JW. Can biomarkers help us hit targets in difficult-to-treat asthma? Respirology. 2017;22(3):430–442. doi:10.1111/resp.1301428248008
   PubMed Web of Science ®Google Scholar
• Centre of Excellence in Severe Asthma. The severe asthma toolkit. Available from: https://toolkit.severeasthma.org.au/. Accessed 715, 2019.
   Google Scholar
• McDonald VM, Vertigan AE, Gibson PG. How to set up a severe asthma service. Respirology. 2011;16(6):900–911. doi:10.1111/j.1440-1843.2011.02012.x21692918
   PubMed Web of Science ®Google Scholar
• Chung LP, Johnson P, Summers Q. Models of care for severe asthma: the role of primary care. Med J Aust. 2018;209(2 Suppl):S34–S40.30453871
   PubMed Web of Science ®Google Scholar
• McDonald VM, Yorke J. Adherence in severe asthma: time to get it right. Eur Respir J. 2017;50:6. doi:10.1183/13993003.00711-2017
   Web of Science ®Google Scholar
• Chuenjit W, Engchuan V, Yuenyongviwat A, Sangsupawanich P. Achieving good adherence to inhaled corticosteroids after weighing canisters of asthmatic children. F1000Res. 2017;6:266. doi:10.12688/f1000research.10710.128868133
   PubMedGoogle Scholar
• McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2012;186(11):1102–1108. doi:10.1164/rccm.201204-0587OC23024023
   PubMed Web of Science ®Google Scholar
• Lindsay JT, Heaney LG. Nonadherence in difficult asthma - facts, myths, and a time to act. Patient Prefer Adherence. 2013;7:329–336. doi:10.2147/PPA.S3820823723690
   PubMed Web of Science ®Google Scholar
• Taylor TE, Zigel Y, Egan C, et al. Objective assessment of patient inhaler user technique using an audio-based classification approach. Sci Rep. 2018;8(1):2164. doi:10.1038/s41598-018-20523-w29391489
   PubMed Web of Science ®Google Scholar
• Lavorini F, Fontana GA, Usmani OS. New inhaler devices-the good, the bad and the ugly. Respiration. 2014;88(1):3–15. doi:10.1159/00036339024902629
   PubMed Web of Science ®Google Scholar
• Faruqi S, Thompson J, Robinson T, et al. Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes? Eur Respir J. 2018;52(suppl62):PA4453. doi:10.1183/13993003.01675-2018
   Web of Science ®Google Scholar
• Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2009;180(9):817–822. doi:10.1164/rccm.200902-0166OC19644048
   PubMed Web of Science ®Google Scholar
• Murphy AC, Proeschal A, Brightling CE, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012;67(8):751–753. doi:10.1136/thoraxjnl-2011-20109622436168
   PubMed Web of Science ®Google Scholar
• Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376(9743):803–813. doi:10.1016/S0140-6736(10)61087-220816547
   PubMed Web of Science ®Google Scholar
• Clark VL, Gibson PG, Genn G, et al. Multidimensional assessment of severe asthma: a systematic review and meta-analysis. Respirology. 2017;22(7):1262–1275. doi:10.1111/resp.1313428776330
   PubMed Web of Science ®Google Scholar
• Gibson P, McDonald V. Phenotyping asthma and COPD. BRN Rev. 2016;2:239–252.
   Google Scholar
• McDonald V, Clark V, Wark P, Baines K, Gibson P. Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT). Eur Respir J. 2017;50(suppl 61):OA1482. doi:10.1183/13993003.00711-2017
   Web of Science ®Google Scholar
• Hudon C, Chouinard M-C, Lambert M, Dufour I, Krieg C. Effectiveness of case management interventions for frequent users of healthcare services: a scoping review. BMJ Open. 2016;6(9):e012353. doi:10.1136/bmjopen-2016-012353
   Web of Science ®Google Scholar
• McDonald VM, Higgins I, Wood LG, Gibson PG. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax. 2013;68(7):691–694. doi:10.1136/thoraxjnl-2012-20264623503624
   PubMed Web of Science ®Google Scholar
• Orozco-Beltrán D, Carratalá-Munuera C, Arriero JM, et al. Management and referral of patients with severe and poorly controlled asthma in primary care. Fam Pract. 2016;33(6):678–683. doi:10.1093/fampra/cmw08127543792
   PubMed Web of Science ®Google Scholar
• Braido F, Baiardini I, Stagi E, et al. Unsatisfactory asthma control: astonishing evidence from general practitioners and respiratory medicine specialists. J Investig Allergol Clin Immunol. 2010;20(1):9–12.
   PubMed Web of Science ®Google Scholar
• Cousins JL, Wark PA, McDonald VM. Acute oxygen therapy: a review of prescribing and delivery practices. Int J Chron Obstruct Pulmon Dis. 2016;11:1067–1075. doi:10.2147/COPD.S10360727307722
   PubMed Web of Science ®Google Scholar
• Morrow S, Daines L, Wiener-Ogilvie S, et al. Exploring the perspectives of clinical professionals and support staff on implementing supported self-management for asthma in UK general practice: an IMP(2)ART qualitative study. NPJ Prim Care Respir Med. 2017;27(1):45. doi:10.1038/s41533-017-0041-y28720751
   PubMed Web of Science ®Google Scholar
• Price D, Bjermer L, Bergin DA, Martinez R. Asthma referrals: a key component of asthma management that needs to be addressed. J Asthma Allergy. 2017;10:209–223. doi:10.2147/JAA.S13430028794645
   PubMed Web of Science ®Google Scholar
• Baiardini I, Braido F, Bonini M, Compalati E, Canonica GW. Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol. 2009;9(3):228–233. doi:10.1097/ACI.0b013e32832b465119390434
   PubMed Web of Science ®Google Scholar
• Lugtenberg M, Zegers-van Schaick JM, Westert GP, Burgers JS. Why don’t physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4:54. doi:10.1186/1748-5908-4-5419674440
   PubMed Web of Science ®Google Scholar
• Lenney W, Bush A, Fitzgerald DA, et al. Improving the global diagnosis and management of asthma in children. Thorax. 2018;73(7):662. doi:10.1136/thoraxjnl-2018-211626
   Web of Science ®Google Scholar
• Moffat M, Cleland J, van der Molen T, Price D. Poor communication may impair optimal asthma care: a qualitative study. Fam Pract. 2007;24(1):65–70. doi:10.1093/fampra/cml06217158184
   PubMed Web of Science ®Google Scholar
• Dombkowski KJ, Hassan F, Wasilevich EA, Clark SJ. Spirometry use among pediatric primary care physicians. Pediatrics. 2010;126(4):682–687. doi:10.1542/peds.2010-036220819894
   PubMed Web of Science ®Google Scholar
• Mazrou SHA. Expected benefits of clinical practice guidelines: factors affecting their adherence and methods of implementation and dissemination. JHS. 2013;1(3):141.
   Google Scholar
• McDonald VM, Gibson PG. The severe asthma toolkit: a new online resource for clinicians. Respir Med Today. 2018;3(1):26–27.
   Google Scholar
• McDonald V, Kennington E, Hyland M. Understanding the experience of people living with severe asthma In: Chung KF, Israel E, Gibson P, editors. Severe Asthma (ERS Monograph). Sheffield: European Respiratory Society; 2019:16–29.
   Google Scholar
• Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020. doi:10.1164/rccm.201804-0682CI29756989
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Canonica GW, Winders TA, et al. A charter to improve patient care in severe asthma. Adv Ther. 2018;35(10):1485–1496. doi:10.1007/s12325-018-0777-y30182174
   PubMed Web of Science ®Google Scholar
• Ryan D, Murphy A, Stallberg B, Baxter N, Heaney LG. ‘SIMPLES’: a structured primary care approach to adults with difficult asthma. Prim Care Respir J. 2013;22(3):365–373. doi:10.4104/pcrj.2013.0007523974674
   PubMedGoogle Scholar
• Laforest L, Van Ganse E, Devouassoux G, et al. Management of asthma in patients supervised by primary care physicians or by specialists. Eur Respir J. 2006;27(1):42–50. doi:10.1183/09031936.06.0003580516387934
   PubMed Web of Science ®Google Scholar
• Dennis SM, Zwar NA, Marks GB. Diagnosing asthma in adults in primary care: a qualitative study of Australian GPs’ experiences. Prim Care Respir J. 2010;19(1):52–56. doi:10.4104/pcrj.2009.0004619623470
   PubMedGoogle Scholar
• Young HN, Len-Rios ME, Brown R, Moreno MM, Cox E. How does patient-provider communication influence adherence to asthma medications? Patient Educ Couns. 2017;100(4):696–702. doi:10.1016/j.pec.2016.11.02227916463
   PubMed Web of Science ®Google Scholar
• Crespo-Lessmann A, Plaza V, González-Barcala F-J, Fernández-Sánchez T, Sastre J. Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma. BMJ Open Respir Res. 2017;4(1):e000189. doi:10.1136/bmjresp-2017-000189
   PubMed Web of Science ®Google Scholar
• Eassey D, Reddel HK, Foster JM, et al. “…I've said I wish I was dead, you'd be better off without me”: A systematic review of people's experiences of living with severe asthma. J Asthma 2019;56(3):311-322.
   Google Scholar
• Moffat M, Cleland J, van der Molen T, Price D. Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J. 2006;15(3):159–165. doi:10.1016/j.pcrj.2006.02.00616757396
   PubMedGoogle Scholar
• Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32(3):545–554. doi:10.1183/09031936.0015530718757695
   PubMed Web of Science ®Google Scholar
• Bidad N, Barnes N, Griffiths C, Horne R. Understanding patients’ perceptions of asthma control: a qualitative study. Eur Respir J. 2018;51(6):1701346. doi:10.1183/13993003.01346-201729773688
   PubMed Web of Science ®Google Scholar
• Lingner H, Burger B, Kardos P, et al. What patients really think about asthma guidelines: barriers to guideline implementation from the patients’ perspective. BMC Pulm Med. 2017;17(1):13. doi:10.1186/s12890-016-0346-628077097
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM. Biomarkers of asthma and allergic airway diseases. Ann Allergy Asthma Immunol. 2015;115(5):335–340. doi:10.1016/j.anai.2015.09.00326505931
   PubMed Web of Science ®Google Scholar
• Ward PR, Rokkas P, Cenko C, et al. ‘Waiting for’ and ‘waiting in’ public and private hospitals: a qualitative study of patient trust in South Australia. BMC Health Serv Res. 2017;17(1):333. doi:10.1186/s12913-017-2281-528476130
   PubMed Web of Science ®Google Scholar
• Normansell R, Welsh E. “Asthma can take over your life but having the right support makes that easier to deal with.” Informing research priorities by exploring the barriers and facilitators to asthma control: a qualitative analysis of survey data. Asthma Res Pract. 2015;1(1):11. doi:10.1186/s40733-015-0011-527965765
   PubMedGoogle Scholar
• Fielden JM, Cumming JM, Horne JG, et al. Waiting for hip arthroplasty: economic costs and health outcomes. J Arthroplasty. 2005;20(8):990–997. doi:10.1016/j.arth.2004.12.06016376253
   PubMed Web of Science ®Google Scholar
• Eguiluz-Gracia I, Tay TR, Hew M, et al. Recent developments and highlights in biomarkers in allergic diseases and asthma. Allergy. 2018;73(12):2290–2305. doi:10.1111/all.1362830289997
   PubMed Web of Science ®Google Scholar
• Berry M, Morgan A, Shaw DE, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007;62(12):1043–1049. doi:10.1136/thx.2006.07342917356056
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360(9347):1715–1721. doi:10.1016/S0140-6736(02)11679-512480423
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360(10):973–984. doi:10.1056/NEJMoa080899119264686
   PubMed Web of Science ®Google Scholar
• Pavlidis S, Takahashi K, Ng Kee Kwong F, et al. “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J. 2019;53:1. doi:10.1183/13993003.01184-2018
   Web of Science ®Google Scholar
• Zhang XY, Simpson JL, Powell H, et al. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clin Exp Allergy. 2014;44(9):1137–1145. doi:10.1111/cea.1234524849076
   PubMed Web of Science ®Google Scholar
• Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163–2173. doi:10.1056/NEJMoa04359615914548
   PubMed Web of Science ®Google Scholar
• Schleich FN, Seidel L, Sele J, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≥3% in a cohort of unselected patients with asthma. Thorax. 2010;65(12):1039–1044. doi:10.1136/thx.2009.12492520671307
   PubMed Web of Science ®Google Scholar
• Jia G, Erickson RW, Choy DF, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012;130(3):647-654.e10.
   Google Scholar
• Simpson JL, Yang IA, Upham JW, et al. Periostin levels and eosinophilic inflammation in poorly-controlled asthma. BMC Pulm Med. 2016;16(1):67. doi:10.1186/s12890-016-0276-327130294
   PubMed Web of Science ®Google Scholar
• Wagener AH, de Nijs SB, Lutter R, et al. External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115–120. doi:10.1136/thoraxjnl-2014-20563425422384
   PubMed Web of Science ®Google Scholar
• Medrek SK, Parulekar AD, Hanania NA. Predictive biomarkers for asthma therapy. Curr Allergy Asthma Rep. 2017;17(10):69. doi:10.1007/s11882-017-0739-528929293
   PubMed Web of Science ®Google Scholar
• Gibson PG. Variability of blood eosinophils as a biomarker in asthma and COPD. Respirology. 2018;23(1):12–13. doi:10.1111/resp.1320029052302
   PubMed Web of Science ®Google Scholar
• Schleich FN, Manise M, Sele J, et al. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med. 2013;13:11. doi:10.1186/1471-2466-13-1123442497
   PubMed Web of Science ®Google Scholar
• Hastie AT, Moore WC, Li H, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol. 2013;132(1):72–80. doi:10.1016/j.jaci.2013.03.04423706399
   PubMed Web of Science ®Google Scholar
• Gibson PG. Inflammatory phenotypes in adult asthma: clinical applications. Clin Respir J. 2009;3(4):198–206. doi:10.1111/j.1752-699X.2009.00162.x20298405
   PubMed Web of Science ®Google Scholar
• Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy. 2011;4:77–86. doi:10.2147/JAA.S1508121792321
   PubMedGoogle Scholar
• Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(4):290–300. doi:10.1016/S2213-2600(15)00050-825801413
   PubMed Web of Science ®Google Scholar
• Trevor JL, Chipps BE. Severe asthma in primary care: identification and management. Am J Med. 2018;131(5):484–491. doi:10.1016/j.amjmed.2017.12.03429355509
   PubMed Web of Science ®Google Scholar
• Mcdonald VM, Maltby S, Clark VL, et al. Development of the Severe Asthma Toolkit: A Clinical Website Resource for the Management of Severe Treatment-refractory Asthma. Respirology 2018;23(S2):28-28.
   Google Scholar
• Alexandrine JL, Sandra P, Roland G, et al. Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Can Respir J. 2013;20(4):285. doi:10.1155/2013/56210423936888
   PubMed Web of Science ®Google Scholar
• Cabana MD, Slish KK, Evans D, et al. Impact of physician asthma care education on patient outcomes. Pediatrics. 2006;117(6):2149–2157. doi:10.1542/peds.2005-105516740859
   PubMed Web of Science ®Google Scholar
• Clark NM, Cabana MD, Nan B, et al. The clinician-patient partnership paradigm: outcomes associated with physician communication behavior. Clin Pediatr (Phila). 2008;47(1):49–57. doi:10.1177/000992280730565017901215
   PubMed Web of Science ®Google Scholar
• Wolf A, Moore L, Lydahl D, et al. The realities of partnership in person-centred care: a qualitative interview study with patients and professionals. BMJ Open. 2017;7(7):e016491. doi:10.1136/bmjopen-2017-016491
   PubMed Web of Science ®Google Scholar
• Apter AJ, Morales KH, Han X, et al. A patient advocate to facilitate access and improve communication, care, and outcomes in adults with moderate or severe asthma: rationale, design, and methods of a randomized controlled trial. Contemp Clin Trials. 2017;56:34–45. doi:10.1016/j.cct.2017.03.00428315481
   PubMed Web of Science ®Google Scholar
• Kane B, Cramb S, Hudson V, et al. Specialised commissioning for severe asthma: oxymoron or opportunity? Thorax. 2016;71(2):196–198. doi:10.1136/thoraxjnl-2015-20738026609007
   PubMed Web of Science ®Google Scholar
• Loscalzo J, Kohane I, Barabasi AL. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007;3:124. doi:10.1038/msb410016317625512
   PubMed Web of Science ®Google Scholar
• Ritchie MD, de Andrade M, Kuivaniemi H. The foundation of precision medicine: integration of electronic health records with genomics through basic, clinical, and translational research. Front Genet. 2015;6:104. doi:10.3389/fgene.2015.0010425852745
   PubMed Web of Science ®Google Scholar
• Verrills NM, Irwin JA, He XY, et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1633–1643. doi:10.1164/rccm.201010-1623OC21471098
   PubMed Web of Science ®Google Scholar
• Baines KJ, Simpson JL, Wood LG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997–1007. doi:10.1016/j.jaci.2013.12.109124582314
   PubMed Web of Science ®Google Scholar
• Kim S, Oesterreich S, Kim S, Park Y, Tseng GC. Integrative clustering of multi-level omics data for disease subtype discovery using sequential double regularization. Biostatistics. 2017;18(1):165–179. doi:10.1093/biostatistics/kxw03927549122
   PubMed Web of Science ®Google Scholar
• Dallinga JW, Robroeks CM, van Berkel JJ, et al. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy. 2010;40(1):68–76. doi:10.1111/j.1365-2222.2009.03343.x19793086
   PubMed Web of Science ®Google Scholar
• Thwaites RS, Jarvis HC, Singh N, et al. Absorption of nasal and bronchial fluids: precision sampling of the human respiratory mucosa and laboratory processing of samples. J Vis Exp 2018(131):e56413.
   Google Scholar
• Melo JT Jr., Tunstall T, Pizzichini MMM, et al. IL-5 levels in nasosorption and sputosorption correlate with sputum eosinophilia in allergic asthma. Am J Respir Crit Care Med. 2019;199(2):240–243. doi:10.1164/rccm.201807-1279LE30335470
   PubMed Web of Science ®Google Scholar
• Restifo LL, Phelan GR. The cultural divide: exploring communication barriers between scientists and clinicians. Dis Model Mech. 2011;4(4):423–426. doi:10.1242/dmm.00817721708897
   PubMed Web of Science ®Google Scholar
• St John A. The evidence to support point-of-care testing. Clin Biochem Rev. 2010;31(3):111–119.24150515
   PubMedGoogle Scholar
• Ferguson BS, Hoggarth DA, Maliniak D, et al. Real-time, aptamer-based tracking of circulating therapeutic agents in living animals. Sci Transl Med. 2013;5(213):213ra165–213ra165. doi:10.1126/scitranslmed.3007095
   PubMed Web of Science ®Google Scholar